80 related articles for article (PubMed ID: 2766891)
1. A rapid and sensitive flow cytometric method for the detection of multidrug-resistant cells.
Herweijer H; van den Engh G; Nooter K
Cytometry; 1989 Jul; 10(4):463-8. PubMed ID: 2766891
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric double labeling technique for screening of multidrug resistance.
Gheuens EE; van Bockstaele DR; van der Keur M; Tanke HJ; van Oosterom AT; De Bruijn EA
Cytometry; 1991; 12(7):636-44. PubMed ID: 1685985
[TBL] [Abstract][Full Text] [Related]
3. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
4. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer.
Alakhov VYu ; Moskaleva EYu ; Batrakova EV; Kabanov AV
Bioconjug Chem; 1996; 7(2):209-16. PubMed ID: 8983343
[TBL] [Abstract][Full Text] [Related]
5. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of adriamycin-resistant human ovarian carcinoma cell line and its mechanism of multidrug resistance].
Li PY; Lin C
Yao Xue Xue Bao; 1995; 30(4):258-62. PubMed ID: 7660793
[TBL] [Abstract][Full Text] [Related]
8. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic membrane cholesterol and doxorubicin cytotoxicity in drug-sensitive and multidrug-resistant human ovarian cancer cells.
Mazzoni A; Trave F
Oncol Res; 1993; 5(2):75-82. PubMed ID: 8364256
[TBL] [Abstract][Full Text] [Related]
10. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
Ross DD; Thompson BW; Ordóñez JV; Joneckis CC
Cytometry; 1989 Mar; 10(2):185-91. PubMed ID: 2714107
[TBL] [Abstract][Full Text] [Related]
11. Drug-resistance associated alterations of cell surface antigen expression in a human anthracycline-resistant ovarian carcinoma cell line.
Sedlák J; McGown A; Hrubisko M; Hunáková L; Chorváth B
Neoplasma; 1994; 41(5):259-62. PubMed ID: 7854495
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
13. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
14. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
15. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
[TBL] [Abstract][Full Text] [Related]
16. Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells.
Mazzoni A; Trave F; Fabbri M; Leto G; Ghidoni R
Anticancer Res; 1991; 11(6):2181-5. PubMed ID: 1776860
[TBL] [Abstract][Full Text] [Related]
17. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
[TBL] [Abstract][Full Text] [Related]
18. Isolation of highly multidrug-resistant P388 cells from drug-sensitive P388/S cells by flow cytometric cell sorting.
Ross DD; Ordóñez JV; Joneckis CC; Testa JR; Thompson BW
Cytometry; 1988 Jul; 9(4):359-67. PubMed ID: 3402281
[TBL] [Abstract][Full Text] [Related]
19. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
[TBL] [Abstract][Full Text] [Related]
20. A unique human ovarian carcinoma cell line expressing CD34 in association with selection for multidrug resistance.
Minderman H; Vanhoefer U; Toth K; Minderman MD; Rustum YM
Cancer; 1996 Dec; 78(11):2427-36. PubMed ID: 8941015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
